Sign Out
BETNOVATE-N is contraindicated in children under 2 years of age.
Due to the known ototoxic and nephrotoxic potential of neomycin sulphate, the use of BETNOVATE-N in large quantities or on large areas for prolonged periods of time is contraindicated in circumstances where significant systemic absorption may occur.
The following conditions should not be treated with BETNOVATE-N: Rosacea; Acne vulgaris; Perioral dermatitis; Pruritus without inflammation; Perianal and genital pruritus; Primary cutaneous viral infections; Primary infected skin lesions caused by infection with fungi, or bacteria; Primary or secondary infections due to yeasts; Secondary infections due to Pseudomonas or Proteus species; Otitis externa when the eardrum is perforated, because of the risk of ototoxicity.
